Comprehensive Heart Health

StoreGene offers the most comprehensive genetic cardiovascular analysis on the market today, bridging the gap between genetics and cardiovascular care, and offering clinicians a powerful tool to provide personalised treatment for individuals.  This analysis represents a significant advancement in preventative cardiovascular medicine, giving individuals the knowledge and support they need to take charge of their heart health. The analysis includes:

Genomic and Conventional Risk Assessment: Analyses 1.7 million variants to calculate your genetic risk score, and combines this with conventional risk factors such as BMI, blood pressure, and cholesterol levels determine the 10-year likelihood of developing cardiovascular disease.

Lipoprotein(a) Polygenic Risk Assessment: LP(a) is similar to LDL cholesterol but more ‘sticky‘, and high levels in the blood are a risk factor for heart disease. This test determines an individual’s genetic risk for levels of Lipoprotein(a) in the blood. 

Familial Hypercholesterolemia Assessment: This  test assesses 9 genes known to have a monogenic cause for this common genetic disorder, which increases levels of LDL cholesterol and can be managed with medication. 

Familial Hypercholesterolemia Polygenic Risk Assessment: This test predicts the levels of Low Density Lipoprotein cholesterol in an individual’s blood. For those with already high cholesterol levels, this can be an indicator of Familial Hypercholesterolemia.

Pharmacogenomic (PGx) Heart Medication Response: Determines metabolising status for several heart medications, including statins, warfarin, and clopidogrel.

Clinicians are equipped with actionable information to create tailored treatment plans. These plans are based on a individuals’s genetic profile, enabling more precise medication selection, lifestyle recommendations, and monitoring strategies

Requirements: Blood Sample or Transfer of Whole Genome Data

Sequencing Time: 30 days

Analysis Time: 24 hours